Form 4: OptimizeRx Corp Executive Doug Besch Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Doug Besch, Chief Product Officer of OptimizeRx Corp, disposed of 1,386 shares of common stock on February 15, 2025, to satisfy tax withholding obligations.
Summary
- On February 15, 2025, Doug Besch, the Chief Product Officer of OptimizeRx Corp, disposed of 1,386 shares of common stock.
- The shares were disposed of at a price of $6.64 per share.
- This transaction was to cover the reporting person's tax withholding obligations.
- Following the transaction, Besch beneficially owns 51,605 shares of OptimizeRx Corp.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. This provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/15/2025 | Date of transaction: Doug Besch disposed of 1,386 shares of OptimizeRx Corp stock. |
| 02/20/2025 | Date of filing: Form 4 filing date. |
Keywords
OptimizeRx Corp, Doug Besch, Form 4, Stock Disposal, Tax Withholding, OPRX, Chief Product Officer, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.